TrialJournal of atherosclerosis and thrombosis2026

The Effects of Pemafibrate on Fibrinogen and Thrombogenicity in Patients with Coronary Artery Disease.

Masanobu Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.